News & Media: Top News
Exciting things are happening at AVITA Medical. Here is the latest news about our company, products, and pipeline.
PRESS RELEASE | JUNE 07, 2023
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
PRESS RELEASE | MAY 15, 2023
AVITA Medical to Host Investor Webinar Briefing
PRESS RELEASE | MAY 11, 2023
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
PRESS RELEASE | APRIL 20, 2023
AVITA Medical to Announce First Quarter 2023 Financial Results
PRESS RELEASE | APRIL 13, 2023
AVITA Medical Announces Update to Automation Device
IN THE NEWS
This article may contain information for uses of our product that are not approved in certain countries or regions.
In the United States, RECELL® is approved for use in patients suffering acute thermal burns. Use of RECELL in other patient populations is either prohibited by United States law or may be made available pursuant to a relevant investigational device exemption granted by the FDA (and likewise limited by United States law to investigational use only) or otherwise prohibited.